E-50 Skin Exosome 產品更新通知

致客戶及合作夥伴：

E-50 Skin Exosome 將於 2025 年 10 月中旬起啟用全新版本，舊有版本三瓶配置亦會全面停產。新版本改為兩瓶組合，包括 E-50 Dry Ampoule 乾粉安瓶及 E-50 Solvent Ampoule 溶劑安瓶。此項調整旨在簡化臨床操作流程，同時維持產品一貫的效能與穩定性。

除了配置上的變更，新版本在質地、吸收效率以及臨床可見效果方面亦有顯著提升。這些改進得益於冷凍乾燥工藝的優化，以及溶劑安瓶原料的升級。目前反饋顯示，相關改善已獲得正面評價，顯示更新後的產品在實際應用中更具優勢。

本次產品更新不涉及價格調整，產品售價將維持不變；感謝各位的理解及配合，如需進一步資訊，請與本公司聯繫。

To Our Valued Clients and Partners,

We would like to inform you that the E-50 Skin Exosome product will be transitioning to a new version starting in mid-October 2025. The original three-ampoule configuration will be completely discontinued. The new version will feature a two-ampoule set, including the E-50 Dry Ampoule and the E-50 Solvent Ampoule. This adjustment is designed to streamline the clinical workflow while maintaining the product's consistent efficacy and stability.

In addition to the configuration change, the new version shows significant improvements in texture, absorption efficiency, and clinically visible results. These enhancements are a direct result of optimized lyophilization processes and the use of upgraded raw materials for the solvent ampoule. We have received positive feedback on these improvements, indicating that the updated product offers a clear advantage in practical application.

The price of the product by this update will remain unchanged. Thank you for your understanding and cooperation. For any further information, please do not hesitate to contact us.

Good Union Corporation Limited

11 September, 2025